Brief: Tempus And Medtronic Announce Alert Trial Results Showing Ai-Driven Ehr Notifications Improve Treatment For Significant Valvular Heart Disease
01/04/2026 14:14
April 1 (Reuters) - Tempus AI Inc TEM.O: TEMPUS AND MEDTRONIC ANNOUNCE ALERT TRIAL RESULTS SHOWING AI-DRIVEN EHR NOTIFICATIONS IMPROVE TREATMENT FOR SIGNIFICANT VALVULAR HEART DISEASE TEMPUS AI INC: STUDY MET ITS PRIMARY ENDPOINT, DEMONSTRATING THAT AUTOMATED ECN ALERTS WERE SUPERIOR TO USUAL CARE IN A WIN RATIO ANALYSIS Source text: ID:nBw30MBkCa Further company coverage: TEM.O ((Reuters.Briefs@thomsonreuters.com;))